Porton Pharma Solutions Ltd. is glad to announce that it scored 38 (out of 100) in the 2023 S&P Global Corporate Sustainability Assessment reflecting an improvement of 9 points based on the 2023 methodology over the last year, where scores in all the three dimensions getting improved and exceeding the industry average. (CSA Score as of 25/08/2023).
Porton continues to gain ground in its environmental, social, and governance initiatives. In 2023, Porton establishes a top-down ESG governance structure, which includes Board Strategy and ESG Committee, ESG Executive Committee and ESG Working Team, to ensure the implementation of responsibilities and management measures. Meanwhile, Porton has identified 19 ESG high material issues and will further address and respond to these issues and enhance ESG performance.
| Governance | Social | Environmental |
| Business ethicsOperational compliance | R&D and innovationIP protectionProduct quality and safetyCustomer serviceData and information securityDigitalizationDiversity, equity and inclusionOccupational health and safetyHuman capital developmentSupply chain securityAccess to healthcare and wellbeingGreen chemistryCommunity communication and development | Environmental policy and management systemsWastewater managementWaste managementClimate change |
For Porton, improving ESG governance and performance is a continuous evolutionary process. We will always be committed to cooperating with all stakeholders to achieve sustainable development.